In the Forum 'Ethical discussions regarding medical cannabis' held by Foros Semana and Khiron Life Science Corp, different topics were analyzed around health care models and alternatives such as cannabis-based medicine. Relevant players like Julio César Aldana (General Director of Invima), Martha Edith Oyuela (Vice President of Health of Khiron), Juan Manuel Galán (Exsenator of the Republic) and Ángela González (Head of Special Programs at Méderi Hospital) participated in the event.

One of the highlights during the Forum was that one of the big challenges is the regulation of medical cannabis for patients who require it. For the Vice President of Health at Khiron, the industry is increasing favorably, but is necessary to continue working in this topic to ensure that people who require it could access the treatment.

However, the Director of Invima said that it is expected that the normative is issued in the next weeks. On the other hand, there is the challenge to educate doctors so they can have an informed relationship with their patients.

Also, other speakers emphasized that this plant is considered relevant for Colombia’s economic development, providing also a new opportunity for the academic sector and helping to break the paradigms that of our society surrounding this alternative.

We need to work in coordination between the different institutions to achieve in short term the prescription and proper use of cannabis-based medicine” said Martha Edith Oyuela, Khiron VP of Health

The forum also highlighted the importance of health care programs to be focused on the needs and preferences of patients and on high quality services that dignify their medical treatments.

For further information, please refer to the original news item

“The bet of medicinal cannabis” [“La apuesta del cannabis medicinal”] 2019. Semana.

Recovered from: